跳至主要内容
临床试验/IRCT20131009014957N15
IRCT20131009014957N15尚未招募1 期

The mesenchymal stem cell-derived extracellular vesicles for primary postmenopausal osteoporosis: A safety, feasibility, and efficacy trial.

Tabriz University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 70 years(—)
性别
Female

入选标准

  • Having the ability to self-care
  • A resident of Tabriz city
  • Cessation of menstruation for at least 12 consecutive months
  • Having a bone density of less than 2.5 in the lumbar vertebrae, pelvis, or femoral neck
  • No history of fracture

排除标准

  • T-score=-4 in lumbar vertebrae, T-score=-3.5 in pelvic bone and femoral neck, history of hip or vertebrae fractures
  • Suffering from renal failure and diseases
  • Having bone diseases other than osteoporosis
  • Taking drugs that affect bone metabolism
  • Having a mental illness according to the patient's own statement
  • Malignancy according to the patient's own statement
  • Peptic ulcers and malabsorption disorders
  • 25-(OH) Vitamin D levels < 20ng/ml or current hypercalcemia or hypocalcemia

研究者

相似试验